Evidence map›Paper›PMID 40491752›Full record

ReviewFrontiers in chemistry2025

A review of combined imaging and therapeutic applications based on MNMs.

Yiqing Yang, Peihong Teng, Shaonan Yu, Yuran Meng, Jinjie Zuo, He Guo, Guifeng Liu

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yiqing YangDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Peihong TengDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Shaonan YuDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Yuran MengDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Jinjie ZuoDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
He GuoDepartment of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Guifeng LiuDepartment of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic nanomaterials (MNMs) are nanoscale materials with inherent magnetic properties that can respond to external magnetic fields, typically composed of magnetic metals or metal oxides. These materials exhibit broad application prospects in medical imaging, targeted drug delivery, and cancer therapy due to their exceptional magnetic properties, biocompatibility, and surface functionalization capabilities. As multifunctional imaging contrast agents, magnetic nanomaterials have been extensively employed in magnetic resonance imaging, computed tomography, and positron emission tomography to enhance multimodal imaging, thereby improving image resolution and diagnostic accuracy. Additionally, as targeted drug carriers, they can be guided by external magnetic fields to achieve precise drug delivery, enhancing therapeutic efficacy while minimizing systemic side effects. In therapeutic applications, magnetic nanomaterials have been utilized in magnetic hyperthermia therapy and photothermal therapy, where they generate localized heat via alternating magnetic fields or photothermal conversion effects, enabling tumor microenvironment modulation and precise tumor ablation. This review systematically summarizes recent advances in the use of MNMs for medical imaging and therapy, with a particular focus on key technical challenges and emerging opportunities to achieve synergistic imaging and therapeutic functions. This work aims to provide valuable insight into the development of MNMs for applications in precision medicine and personalized therapy.

Indexed as

cancer therapymagnetic nanomaterialsmultimodal imagingpersonalized therapytheranostics

Identifiers

PMID40491752
PMCPMC12146317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.